Wheel Health, Inc. announced it received $50 million in funding. The company closed the transaction on May 19, 2021 and amended the terms to reflect $50,000,000 led by new investor Lightspeed Venture Partners. Participation in the round included existing investors Charles River Ventures, Silverton Partners, JPMorgan Chase & Co., and Tusk Venture Partners, plus new investor Future Shape LLC. As part of the transaction, Ling Wong from Lightspeed joined Wheel Health's board of directors. Prior to this deal the company had raised $34,999,992 from five investors pursuant to Regulation D. The announcement does not disclose product details, operating metrics, or other financial specifics beyond the funding and the Regulation D disclosure. Enzyme Health operates a two-sided recruiting marketplace connecting clinicians (doctors and nurse practitioners) with clinical telehealth jobs. The platform serves employers such as Doctor on Demand, MDLive, InTouch Health, Hims/Hers and Parsley Health to help them scale nationwide. Approximately 90% of available positions on the marketplace enable clinicians to work remotely. Machine-learning is used to match clinicians to positions based on expertise and availability. The company was founded in 2018 by Michelle Davey, Griffin Mulcahey and Philip Johnson and is based in Austin, TX. Enzyme Health raised $1.7M in seed funding and intends to use the proceeds to continue expanding operations; no revenue or user metrics were disclosed in the article.

Total raised

$52M

Funding rounds

2

Latest round

Equity

Latest activity

May 2021